Study of Y90-Radioembolization With Nivolumab in Asians With Hepatocellular Carcinoma
Clinical trial NCT03033446 · COMPLETED
Trial details
- NCT number
- NCT03033446
- Sponsor
- National Cancer Centre, Singapore
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-12-20
- Primary completion
- 2019-08-31
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.